Autoimmune lymphoproliferative syndrome causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Autoimmune lymphoproliferative syndrome}} | {{Autoimmune lymphoproliferative syndrome}} | ||
{{CMG}} | {{CMG}} {{SharmiB}} | ||
==Overview== | ==Overview== | ||
Revision as of 04:07, 3 August 2021
|
Autoimmune lymphoproliferative syndrome Microchapters |
|
Differentiating Autoimmune lymphoproliferative syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Autoimmune lymphoproliferative syndrome causes On the Web |
|
American Roentgen Ray Society Images of Autoimmune lymphoproliferative syndrome causes |
|
Directions to Hospitals Treating Autoimmune lymphoproliferative syndrome |
|
Risk calculators and risk factors for Autoimmune lymphoproliferative syndrome causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Sharmi Biswas, M.B.B.S
Overview
The autoimmune lymphoproliferative syndrome is a disease caused by the defect in FAS-mediated apoptosis.
Causes
- Most of the cases autosomal dominant, heterozygous germline mutation in FAS. [1]
- Somatic FAS mutation is the second most common cause.
- Minority of cases mutations in the genes encoding FAS ligand, caspase 10, caspase 8, and neuroblastoma RAS.
- One-third of patients have unidentified genetic defects.
References
- ↑ Oliveira, Joao B.; Bleesing, Jack J.; Dianzani, Umberto; Fleisher, Thomas A.; Jaffe, Elaine S.; Lenardo, Michael J.; Rieux-Laucat, Frederic; Siegel, Richard M.; Su, Helen C.; Teachey, David T.; Rao, V. Koneti (2010). "Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop". Blood. 116 (14): e35–e40. doi:10.1182/blood-2010-04-280347. ISSN 0006-4971.